RNS Number : 9931LAlliance Pharma PLC18 May 2022

For immediate release

18 May 2022

ALLIANCE PHARMA PLC

("Alliance" or the "Company")


Result of AGM

Alliance Pharma plc(AIM: APH), the international healthcare group, announces that, at its Annual General Meeting held earlier today, all the resolutions, as set out in the Notice of Meeting, were duly passed on a poll.

The votes were as follows:

RESOLUTION

VOTES FOR

%

VOTES AGAINST

%

VOTES TOTAL

% OF ISC VOTED

VOTES WITHHELD

1

Report and Accounts

371,393,469

99.99

30,000

0.01

372,087,366

68.97

663,897









2

Final dividend

372,086,356

100.00

0

0.00

372,087,366

68.97

1,010









3

Re-elect P. Butterfield

371,812,794

99.94

238,118

0.06

372,087,366

68.97

36,454









4

Re-elect D. Cook

304,867,206

91.75

27,427,589

8.25

372,087,366

68.97

39,792,571









5

Re-elect A. Franklin

371,701,797

99.91

346,094

0.09

372,087,366

68.97

39,475









6

Re-elect R. Jones

318,832,469

94.70

17,845,835

5.30

372,087,366

68.97

35,409,062









7

Re-elect J. LeCouilliard

283,289,848

84.14

53,391,477

15.86

372,087,366

68.97

35,406,041









8

Elect K. Neirynck

371,168,677

99.76

882,235

0.24

372,087,366

68.97

36,454









9

Re-appoint Auditor

372,018,741

99.99

38,636

0.01

372,087,366

68.97

29,989









10

Remuneration of Auditor

372,058,198

100.00

2,200

0.00

372,087,366

68.97

26,968









11

Allot shares

314,847,187

84.62

57,236,109

15.38

372,087,366

68.97

4,070









12

Disapply Pre-emption rights

318,400,733

85.57

53,682,363

14.43

372,087,366

68.97

4,270

The number of the Group's shares in issue as at the date of the meeting was 539,461,338ordinary shares of 1p each.

Please note that each share carries one vote and that a 'vote withheld' is not a vote in law and has not been counted in the calculation of the proportion of the votes for and against the resolution. Any proxy appointments which gave discretion to the Chairman have been included in the 'votes for' total.

Chris Chrysanthou
Head of Legal & Company Secretary
18 May 2022

For further information:

Alliance Pharma plc

+ 44 (0)1249 466966

Cora McCallum, Head of Investor Relations & Corporate Communications

+ 44 (0)1249 705168

[email protected]




Buchanan

+ 44 (0)20 7466 5000

Mark Court / Sophie Wills / Hannah Ratcliff


[email protected]




Numis Securities Limited

+ 44 (0)20 7260 1000

Nominated Adviser: Freddie Barnfield / Duncan Monteith


Corporate Broking: James Black




Investec Bank plc

+ 44 (0)20 7597 5970

Corporate Finance: Daniel Adams


Corporate Broking: Patrick Robb


About Alliance

Alliance Pharma plc (AIM: APH) is an international healthcare group. Our purpose is to improve the lives of consumers and patients through making available a range of clinically valuable healthcare products.

Our core focus is on the marketing of Consumer Healthcare brands, complemented by a smaller Prescription Medicines business. In total, we hold marketing rights to around 80 brands, with revenues generated from a mix of direct, distributor and e-commerce sales.

Headquartered in the UK, Alliance employs around 250 people based in locations across Europe, North America, and the Asia Pacific region. By outsourcing our manufacturing and logistics operations, we remain asset-light and focused on maximising the value of our brands.

For more information on Alliance, please visit our website: www.alliancepharmaceuticals.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDRAGBKFBQQBKDKPD


The service was requested through Alliance Pharma PLC. To modify your subscription, please subscribe again. If you no longer wish to receive these emails, you may unsubscribe at any time.
Supplied